While the known EN1 motif was enriched in the triple‐negative breast cancer (TNBC) cell lines,[23] we found minimum overlaps of EN1 peaks between PDA and TNBC cells (Figure S4C, Supporting Information), suggesting EN1 genomic targets could differ depending on tissue or cell types. Here, EN1 is linked to Patent ductus arteriosus.